“…Because the disease mechanisms are now fairly well known, today's strategy of early pharmacological treatment and new biological drugs have lead to reduced disease activity and less disability compared to previously [4,5]. However, even in early RA many patients still report disability, implying a persistent need for rehabilitative interventions and medication, and probably also improvements of clinical reasoning with respect to rehabilitation strategies [3,6,7]. In comparison with the greatly developed knowledge of biological aspects of the disease, it is necessary to learn more about patients' perspectives of disabling mechanisms in order to improve the rehabilitation part of clinical interventions.…”